Adding an immunotherapy agent to the standard therapy for HER2+ metastatic breast cancer can significantly…
karnottDecember 11, 2023
Spinal muscular atrophy (SMA) is caused by mutations in SMN1. SMN2 is a paralogous gene…
karnottDecember 7, 2023
Cytokines mediate cell–cell communication in the immune system and represent important therapeutic targets. A myriad…
karnottDecember 7, 2023
The BRI Research Excellence Awards, which promote the research of promising BWH junior investigators and…
karnottDecember 7, 2023
The “in silico–in vitro–in vivo” funnel holds significant potential for identifying targets to control cellular…
karnottNovember 28, 2023
Dana-Farber Cancer Institute is proud to announce that 34 of its researchers have been named…
karnottNovember 27, 2023
Anna Berenson, a PhD candidate of the Fuxman Bass Lab, received joint first place in…
karnottNovember 24, 2023
The Doris Duke Foundation (DDF) announced Zuzana Tothova, MD, PhD, an investigator in the Department…
karnottNovember 23, 2023
